Overview
Dr. Keller joined the Division of Pulmonary and Critical Care Medicine in March 2021 as an Assistant Professor and currently attends in the medical intensive care unit and the cardiac surgical intensive care unit. His primary clinical interest is care of patients with critical illness with a focus on advanced mechanical support of respiratory and circulatory failure. Prior to joining Johns Hopkins, Dr. Keller was faculty at Harvard Medical School and an attending physician at Brigham and Women's Hospital where he served as the inaugural Medical Director of the Extracorporeal Membrane Oxygenation Service. Clinically, he attended on the lung transplant service and also in the medical intensive care unit and cardiac surgical intensive care unit. He received his medical degree from Stanford University and completed residency training in internal medicine at the Massachusetts General Hospital prior to completing fellowship training in pulmonary and critical care medicine at Johns Hopkins Hospital and the National Institutes of Health. Before pursuing a career in medicine, Dr. Keller received his undergraduate degree from Purdue University in electrical engineering and his master’s in semiconductor physics at Cambridge University where he studied as a Churchill Scholar. He received his doctorate in medical engineering from the Massachusetts Institute of Technology where he was awarded the Department of Defense and National Science Foundation graduate fellowships. Dr. Keller conducts translational research on mechanical circulatory support, organ-device interactions, and extracorporeal organ perfusion.
His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Pneumonia, Severe Acute Respiratory Syndrome (SARS), and Lung Transplant.
Dr. Keller is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial. Dr. Keller is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
4940 Eastern Avenue, Baltimore, MD 21224
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Inova Medical Group - Transplant Specialties
Dr. Christopher S. King is a transplant pulmonologist and the Chief of Cardiovascular Critical Care at Inova Fairfax Hospital. He also serves as the Associate Medical Director of the Transplant and Advanced Lung Disease Program, Director of the Cardiovascular Intensive Care Unit at Inova Fairfax Hospital, the Pulmonary Fibrosis Foundation Center Director, and System Director of Respiratory Care Services for Inova. Dr. King is board certified in internal medicine, pulmonary medicine and critical care medicine. Dr. King serves as both a transplant pulmonologist and a medical intensivist for the medical critical care service at Inova Fairfax Hospital. He is also an Associate Clinical Professor of Medicine for the University of Virginia School of Medicine. Dr. King is a member of the medical honor society, Alpha Omega Alpha. While on active duty in the United States Army, he completed tours in Korea and Afghanistan as well as serving in Virginia and Texas. Dr. King has participated in clinical research throughout his training and during his tenure at Inova. His research interests are broad and include venous thromboembolism, interstitial lung disease and pulmonary hypertension. He has coauthored numerous publications including original research and review articles. He has lectured at national conferences and currently serves as a panel member for the American College of Chest Physicians' guidelines on antithrombotic disease. Dr. King is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Hypertension, Lung Transplant, and Endoscopy. Dr. King is currently accepting new patients.
Inova Loudoun Hospital
Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Clinical Medicine at Georgetown University School of Medicine and an Associate Clinical Professor of Medicine at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. Blog Posts What is Pulmonary Hypertension? Learn the Facts to Breathe Easy (November 2018) Pulmonary Hypertension is Serious. Learn to Spot the Signs (May 2017). Dr. Shlobin is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Endoscopy. Dr. Shlobin is currently accepting new patients.
Inova Medical Group - Transplant Specialties
Whitney Brown, MD, is director of Clinical Operations and medical director of the Cystic Fibrosis and Bronchiectasis Program at Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. Dr. Brown has been with the Inova Advanced Lung Disease and Transplant Program since 2010. She is board certified in pulmonary disease, critical care medicine and internal medicine Dr. Brown has a special interest in idiopathic pulmonary fibrosis (IPF), lung transplant outcomes and the care of adult cystic fibrosis patients. She enjoys conducting outcomes-based research and has co-authored two original research articles on IPF, one on prognosis in IPF and the other on the impact of hospitalization on IPF. Dr. Brown is a member of the American Thoracic Society and the International Society for Heart and Lung Transplantation. Dr. Brown is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy. Dr. Brown is currently accepting new patients.
Frequently Asked Questions about Dr. Steve P. Keller
How do I make an appointment with Dr. Steve P. Keller?
You can book an appointment with Dr. Steve P. Keller by calling their office at 410-550-0100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Steve P. Keller a top-rated expert for Acute Respiratory Distress Syndrome (ARDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steve P. Keller is classified as an Experienced expert for Acute Respiratory Distress Syndrome (ARDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Steve P. Keller specialize in?
While Dr. Steve P. Keller is a Pulmonary Medicine, they have specific expertise in Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, and Lung Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Steve P. Keller participate in research or clinical trials?
Yes. Dr. Steve P. Keller has published 57 articles and abstracts on conditions like Acute Respiratory Distress Syndrome (ARDS). You can view a list of Dr. Steve P. Keller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Steve P. Keller accept my insurance?
Dr. Steve P. Keller accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-0100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Cerebral HypoxiaDr. Keller isExperienced. Learn about Cerebral Hypoxia.
- COVID-19Dr. Keller isExperienced. Learn about COVID-19.
- Lung TransplantDr. Keller isExperienced. Learn about Lung Transplant.
- PneumoniaDr. Keller isExperienced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)